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Abstract
Background:  In an effort to identify alternate recombinant gene expression systems in
Pseudomonas fluorescens, we identified genes encoding two native metabolic pathways that were
inducible with inexpensive compounds: the anthranilate operon (antABC) and the benzoate operon
(benABCD).
Results: The antABC and benABCD operons were identified by homology to the Acinetobacter sp.
anthranilate operon and Pseudomonas putida benzoate operon, and were confirmed to be regulated
by anthranilate or benzoate, respectively. Fusions of the putative promoter regions to the E. coli
lacZ gene were constructed to confirm inducible gene expression. Each operon was found to be
controlled by an AraC family transcriptional activator, located immediately upstream of the first
structural gene in each respective operon (antR or benR).
Conclusion: We have found the anthranilate and benzoate promoters to be useful for tightly
controlling recombinant gene expression at both small (< 1 L) and large (20 L) fermentation scales.
Background
Ideally, to facilitate control of gene expression for produc-
tion of proteins in an organism like P. fluorescens, which
has been developed as a robust recombinant protein
expression system[1,2], it is desirable to have a collection
of expression cassettes. These cassettes would contain a
variety of promoters that are tightly regulated, of differing
strengths, induced under different growth conditions,
and/or by different chemicals. These expression cassettes
can then be linked to various genes of interest to achieve
total control of those genes under typical fermentation
conditions. High levels of gene expression are often
obtained in the P. fluorescens system using the E. coli
lacUV5 and tac promoters [1]. Several bacterial promoters
have been previously shown to be effective at driving
transgene expression in pseudomonads including the bac-
teriophage λ PR and PL promoters [3,4], which are regu-
lated by a temperature sensitive repressor protein, and the
Pseudomonas Pm, Pu, and Psal promoters [4,5], which are
regulated by alkyl- or halotoluenes (Pm and Pu) or saly-
cilates (Psal) and the T7 early promoter [6], regulated by
isopropyl-thiogalactopyranoside (IPTG).
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Pseudomonads are capable of metabolizing a wide variety
of aromatic hydrocarbons, including benzoate and
anthranilate [7-11], which are inexpensive and non-toxic.
Benzoate and anthranilate are converted to catechol by
benzoate 1,2-dioxygenase together with 2-hydro-
1,2dihydroxybenzoate dehydrogenase, and anthranilate
1,2-dioxygenase respectively. These enzymes are encoded
by the benABCD and antABC operons, which have been
identified in several organisms [9-16], and are often regu-
lated by transcriptional activators belonging to the AraC/
XylS family of transcriptional regulators. Transcriptional
activators BenR and BenM have been described, which
activate transcription of the benABCD operon [7,17,18].
Recently transcriptional activators of two different anthra-
nilate operons have been described [10,13].
We describe in this report the identification of the P. fluo-
rescens  strain MB214 benABCD  and  antABC  operons,
along with the genes coding for the transcriptional regula-
tory proteins BenR and AntR, respectively. The promoter
regions of the benABCD and antABC operons have been
defined, and regulation by BenR and AntR examined. A
range of potential inducing compounds, in addition to
benzoate and anthranilate, were tested including o-tolu-
ate,  m-toluate,  p-toluate and chlorinated anthranilates.
Promoter elements are defined which are capable of driv-
ing heterologous gene expression at both small (1 L shake
flask) and large (20 L fermentor) scales.
Results
P. fluorescens MB214 can utilize anthranilate and 
benzoate as sole carbon source
To characterize the functional catabolic and regulatory
potential of Pseudomonas fluorescens strain MB214 (Table
1), the strain was tested for the ability to utilize a variety
of aromatic and aliphatic hydrocarbons or aromatic acids
as sole sources of carbon for growth. Carbon substrates
were supplied at 5–10 mM as sole source of carbon and
energy in liquid minimal medium (M9 containing 1 mM
MgSO4 and 5 mg/ml trace metals solution), unless stated
otherwise. Growth in liquid media was measured spectro-
photometrically at 600 nm. In most cases, growth was
also examined on solid media of identical composition
but containing 1.5% (w/v) agar. Naphthalene and toluene
were supplied in the vapor phase to agar plates containing
carbon-free M9 medium. Growth of strain MB214 in
media containing test substrates was compared to that
observed in control media lacking a carbon test substrate.
Results of the phenotypic screens showed that benzoate,
anthranilate, 1-decanol, and 1-dodecanol were able to
support growth of P. fluorescens. However, salicylate, phe-
nylacetate, phthalate, phenol, naphthalene, n-octane, n-
decane, n-dodecane, n-hexadecane and toluene were not
able to support grow of P. fluorescens.
Subsequent experiments conducted in M9 media with
glucose, glycerol, citrate, or succinate as primary growth
substrates indicated that benzoate and anthranilate catab-
olism in strain MB214 was inducible by addition of the
individual aromatic acid substrates. The functional evi-
dence for catabolic pathways inducible by benzoate and
anthranilate, or their metabolic intermediates, led to a
systematic isolation and evaluation of the corresponding
regulatory switches for the development of gene expres-
sion systems.
Characterization of the anthranilate and benzoate 
metabolic operons
Sequence analysis and annotation of the P. fluorescens
MB214 genome in comparison to public databases
revealed putative anthranilate and benzoate operons sim-
ilarly structured to the genes encoding the dioxygenase
and reductase subunits clustered in one operon down-
stream of an AraC/XylS type transcriptional activator,
likely driven by its own promoter (Figure 1). A second
putative transcriptional activator, RXF04732, was identi-
fied downstream of the putative benABCD operon as well.
As described later in this report, it is the upstream tran-
scriptional activator that acts on the Pben promoter. The
genes encoding the putative transcriptional activators,
antR and benR, are orientated differently with respect to
each dioxygenase operon (see Figure 1). Similar to other
AraC/XylS type regulators and the recently described Bur-
kholderia cepacia DBO1 andR gene [13], antR is oriented
divergently from the putative antABC operon. However,
benR is oriented in the same direction as benABCD, similar
to the benR gene of Pseudomonas putida [7].
The proteins coded by the anthranilate and benzoate
operons were compared to the UniProt protein database
(01/05) using the BLASTP program [19]. A comparison of
the AntA, AntB and AntC proteins to homologues of P.
aeruginosa, P. putida and P. resinovorans is shown in Table
2. The P. fluorescens MB214 AntA, AntB, AntC and AntR
proteins, were most similar to those P. resinovorans. Anal-
ysis of P. fluorescens BenA, BenB, BenC, BenD and BenR
protein to homologues of P. aeruginosa and P. putida is
shown in Table 3. These proteins were found to be homol-
ogous to those coded by the P. aeruginosa toluate 1,2-diox-
Table 1: Bacterial strains used in this study
Genus, Species Strain Name Relevant Genotype
Escherichia coli JM109 lacZ-
Pseudomonas fluorescens MB101 lacZ-
Pseudomonas fluorescens MB214 lacZ+
Pseudomonas fluorescens DC164 lacZ- ∆pyrF
Pseudomonas fluorescens DC253 lacZ- ∆benAB
Pseudomonas fluorescens DC284 lacZ- benR::pCR2.1Microbial Cell Factories 2006, 5:1 http://www.microbialcellfactories.com/content/5/1/1
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ygenase and P. putida benzoate catabolic operons. The
similarity of these proteins to those coded for by previ-
ously identified catabolic operons, together with the func-
tional characterization of anthranilate and benzoate
metabolism, indicate that these operons likely code for
the anthranilate and benzoate operons of P. fluorescens.
Isolation of the Pant and Pben promoters
Initially, approximately 500–700 bp regions upstream of
the antA and benA genes (Figure 2) were amplified and
cloned upstream of the lacZ reporter gene in pDOW1017.
As shown in Figure 3A and 3B the resulting plasmids,
pDOW1019 and pDOW1029 are found to contain ben-
zoate and anthranilate inducible promoters, respectively.
Uninduced cultures showed low level β-galactosidase
activity in the presence of the Pben::lacZ fusion. However,
no β-galactosidase activity was detected in uninduced cul-
tures carrying the Pant::lacZ fusion. The Pben and Pant
promoter containing fragments were next truncated to
include only the region between the putative translation
start of the first gene of the structural operon (benA and
antA  respectively) and the upstream putative transcrip-
tional activator open reading frame (ORF). The truncated
benzoate promoter fragment, Pben278, was amplified
and cloned upstream of the lacZ  reporter gene in
pDOW1017. The P. fluorescens strain MB101 (Table 1)
was transformed with the resulting construct,
pDOW1028, and induced with benzoate to assess activity.
Figure 3A shows that Pben278 exhibits benzoate induci-
ble activity similar to Pben509, indicating that the 275 bp
truncated promoter contains all elements necessary for
benzoate-activated transcription. Moreover, the Pben
fragment was further truncated at the 3' end to just 87 bp
based on primer extension mapping of the transcriptional
start site as described below. Similar to Pben278, Pben87
was also found to be as active as the original Pben509
fragment (data not shown). Refined annotation of the 5'
region of the benA gene showed the translation start to be
25 base pairs downstream of the 3' end of Pben87 (see
Figure 2). The truncated anthranilate promoter fragment,
Pant311, was amplified and cloned upstream of the lacZ
reporter gene of pDOW1017. Little activity was detected
from the truncated promoter when fused to the lacZ
reporter gene (data not shown).
Overexpression of transcriptional activator increases Pant 
activity
In an attempt to improve the activity of the anthranilate
inducible promoter, the promoter fragment was ampli-
fied to include the putative transcriptional activator ORF
directly upstream of antA. This PCR fragment was cloned
upstream of the lacZ reporter gene of pDOW1017. MB101
was transformed with the resulting plasmid, pDOW1035,
and activity upon induction with anthranilate was
assessed. The addition of the transcriptional activator in
multicopy demonstrated faster and greater induction
compared to Pant713 (Figure 3B), which does not contain
the entire transcriptional activator ORF. The activity of the
culture harbouring pDOW1035 peaks early, then declines
between 6 and 24 hours. This is likely due to the rapid
decline in anthranilate concentration, compared to the
culture carrying pDOW1029 (data not shown). Similar
experiments were performed with a fragment containing
benR and the Pben509 fragment, however no difference in
promoter activity were observed (data not shown).
Inactivation of the benABCD operon transcriptional 
activator
There are two putative transcriptional regulator coding
sequences that flank the benABCD. To determine if the
ORF benR, upstream of benABCD, acts as the benzoate
transcriptional activator, we insertionally inactivated benR
as described in Materials and Methods. Following inacti-
vation of the putative benzoate transcriptional activator,
the resultant strain DC284 was transformed with the
Pben::lacZ fusion, pDOW1019, and tested for benzoate
activated lacZ expression. As shown in Figure 4A, inactiva-
tion of benR results in an inability to activate Pben::lacZ
expression. Moreover, benzoate is not metabolized as in
the wild-type MB101 strain (Figure 4B) indicating that the
chromosomal benzoate dioxygenase operon (benABCD)
also fails to be induced in the transcriptional activator
knockout strain.
Anthranilate and benzoate operons Figure 1
Anthranilate and benzoate operons. Above are 
depicted schematic representations (not drawn to scale) of 
the P. fluorescens MB214 anthranilate (antR antABC Genbank 
accession number DQ172833) and benzoate (benR benABCD 
Genbank accession number DQ172832) metabolic operons. 
Open reading frames for each gene are indicated by arrows, 
with the direction of the arrow corresponding to the direc-
tion of the open reading frame. Gene names are indicated 
below each arrow.
antR antA antB antC antR antA antB antC
benR benA benB benC benD benR benA benB benC benD RXF04732Microbial Cell Factories 2006, 5:1 http://www.microbialcellfactories.com/content/5/1/1
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Alternative inducers of Pant and Pben promoters
Ortho-, meta- and para-toluate were tested as inducers of
Pant and Pben. Similar to other systems [11,16], m-tolu-
ate was found to be an inducer of the P. fluorescens ben-
zoate operon promoter. Addition of 5 mM m-toluate
induced Pben278 (pDOW1028) to significant levels, ~13
fold over background (Figure 5). However, addition of 5
mM  o-toluate and p-toluate induced Pben278 only
slightly. The antR-Pant construct (pDOW1035) was
induced by 5 mM o-toluate approximately 19- fold over
background, although to levels still lower than m-toluate
induction of Pben (Figure 5). P. fluorescens growth on
solid medium consisting of 1XM9 salts supplemented
with either m-, o-, or p-toluate (5 mM) as a sole carbon
source was tested in comparison to growth on similar
solid medium supplemented with 0.5% glucose as a car-
bon source. While P. fluorescens grew on medium supple-
mented with glucose, growth on m-, o-, or p-toluate as
carbon source was not observed even after 14 days of incu-
bation (data not shown). These results indicated that
although m-, o- and p-toluate could not be utilized as car-
bon sources, certain forms of toluate can act as significant
inducers of the Pben278 and antR-Pant promoter fusions.
Analysis of anthranilate catabolism in strain MB214
revealed that several chloro-anthranilates acted as induc-
ers of the anthranilate catabolic pathway (data not
shown). The pDOW1035 construct containing antR-Pant,
which showed higher expression levels than pDOW1029
(Pant713), was used to compare Pant induction by 2 mM
6-chloro-anthranilate to that by 2 mM anthranilate. As
shown in Figure 6A, the level induction of the antR-
Pant::lacZ fusion by 6-chloroanthranilate was similar to
that measured with anthranilate. Induction with 6-chloro-
anthranilate showed a steady increase in promoter activity
over time, which appeared to level between 6 and 8 hours.
Induction with anthranilate showed a rapid increase in
promoter activity between 4 and 6 hours, which then
declined from 6 to 8 hours. The decline in activity was
likely to due to metabolism of the inducer. Figure 6B
shows concentration of the inducing compounds
throughout the time course of induction. While the con-
centration of 6-chloroanthranilate decreased slightly dur-
ing the time course, the concentration of anthranilate
decreased significantly. These results indicate not only
that 6-chloroanthranilate can act as an inducer of Pant,
but that it may act as a gratuitous inducer, as it does not
appear to be metabolized significantly by P. fluorescens.
Table 2: Anthranilate operon homologues. Percent amino acid identity/similarity shown below. AntA: P. aeruginosa 
(UNI_TREMBL:Q9I0X0); P. putida (UNI_TREMBL:Q93SR3),, and P. resinovorans (GenPept: NP_758565). AntB: P. aeruginosa 
(UNI_TREMBL:Q9I0SR8); P. putida (UNI_TREMBL:Q90W9); P. resinovorans (GenPept: NP_758547). AntC: P. aeruginosa 
(UNI_TREMBL:Q90W8); P. putida (UNI_TREMBL:Q93SR4), P. resinovorans (GenPept: NP_758546). Anthranilate dioxygenase 
transcriptional activator AntR: P. resinovorans (GenPept: NP_758551).
P. aeruginosa homologue 
(%identity/similarity)
P. putida homologue (identity/
similarity)
P. resinovorans homologue 
(%identity/similarity)
P. fluorescens AntA 80/90 45/66 91/95
P. fluorescens AntB 71/81 71/82 74/85
P. fluorescens AntC 63/77 63/77 74/84
P. fluorescens AntR 74/86
Table 3: Benzoate operon homologues. Percent amino acid identity/similarity shown below. BenR: XylS of P. aeruginosa 
(UNI_TREMBL:Q9I0W3) and P. putida (UNI_SPROT:XYS3_PSEPU). BenA: P. aeruginosa toluate 1,2 dioxygenase alpha subunit 
(UNI_TREMBL:Q9I0W4); P. putida BenA (UNI_TREMBL:Q88I40). BenB: P. aeruginosa toluate 1, 2-dioxygenase small subunit 
(UNI_TREMBL:Q9I0W5); P. putida BenB (UNI_TREMBL:Q88I39). BenC: P. aeruginosa toluate 1,2 dioxygenase subunit 
(UNI_TREMBL:Q9WWV0); P. putida BenC (UNI_TREMBL:Q88I38). BenD: P. aeruginosa cis 1,2-dihydroxycyclohexa-3,4-diene 
carboxylate dehydrogenase (UNI_TREMBL:Q9I0W7); P. putida BenD (UNI_TREMBL:Q88I37).
P. aeruginosa homologue (% identity/similarity) P. putida homologue (% identity/similarity)
P. fluorescens BenA 64/79 64/79
P. fluorescens BenB 66/78 70/79
P. fluorescens BenC 53/68 53/68
P. fluorescens BenD 77/84 75/82
P. fluorescens BenR 58/73 54/70Microbial Cell Factories 2006, 5:1 http://www.microbialcellfactories.com/content/5/1/1
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Mapping transcriptional start sites of Pben and Pant 
promoters
Total RNA was isolated from benzoate induced cultures of
MB101 carrying either pDOW1019 (Pben509) or
pDOW1028 (Pben278). Total RNA from each was sub-
jected to primer extension analysis using the lacZPE
primer. Both constructs show the transcriptional start at a
cystine nucleotide 196 bp upstream of the 3' end of the
Pben278 clone (Figure 7A). This is consistent with the
location of the putative -35 and -10 promoter sequences
shown in italics and underlined in Figure 7C.
Total RNA was isolated from an anthranilate induced cul-
ture of MB101 carrying pDOW1029 (Pant713). Primer
extension analysis was performed using the lacZPE2
primer. An extension product was observed correspond-
ing to the adenosine nucleotide 31 bases upstream of the
3' end of the Pant713 clone (Figure 7B). This start site is
consistent with the spacing of the putative -10 and -35
promoter sequences shown in italics and underlined in
Figure 7D.
Analysis of Pben and Pant activity at the 20 L fermentation 
scale
P. fluorescens MB101 carrying the plasmid pDOW1028
(Pben278 promoter) was grown in a standard 20 L fer-
mentation, as described in Materials and Methods, and
induced with 6 mM sodium benzoate. Promoter activity
was monitored as a function of lacZ expression over the
time course of the fermentation. However, under standard
conditions using glucose as a carbon source, no promoter
activity was observed. This was not consistent with results
using glucose as a carbon source shown at the shake flask
scale (Figure 3). Additional shake flask experiments
revealed that the Pben278 promoter was active when
either citrate or glycerol was used as a carbon source as
well (data not shown). When glycerol was used in place of
glucose as a carbon source for 20 L fermentation, Pben278
activity was observed following induction with benzoate,
and increased over the course of the fermentation (Figure
8A). The level of induction was comparable to that
observed at the shake flask scale.
The antR-Pant construct pDOW1035 was also tested at the
20 L scale. MB101 carrying pDOW1035 was grown under
standard fermentation condition, with glucose as a car-
bon source. Following induction with either 5 mM or 10
mM anthranilate, promoter activity was observed (Figure
8B). The culture induced with 10 mM anthranilate
showed a higher level of activity than that induced with 5
mM anthranilate, as expected. Activity was not detected
until very late in the fermentation unlike Pben278, which
showed an increase in activity between 6 and 24 hours
(Figure 8A).
Benzoate induces Pben509
To determine whether benzoate is in fact the inducer of
the Pben509 promoter and not a downstream metabolite,
we sought to block the metabolism of benzoate at the first
step by deleting the benA and benB genes, which code for
the large and small subunits of benzoate 1, 2-dioxygenase
respectively. A deletion of benAB was constructed in the
∆proC∆pyrF strain DC164 as described in Materials and
Methods. The resultant strain, DC253, was tested for the
ability to metabolize benzoate and for the ability to sup-
port benzoate induced β-galactosidase activity from the
Pben509::lacZ construct. To test Pben activity, DC253 was
transformed with pDOW1019 and the resultant strain
was induced with 5 mM benzoate. As shown in Figure 9A,
Pben509::lacZ  remains active in the benAB  knockout
strain, i.e. β-galactosidase activity is detected. The concen-
tration of benzoate remaining in the cell-free broth as
measured by HPLC showed that the benAB  deletion
mutants were unable to metabolize benzoate, while the
parent strain DC164 did metabolize benzoate efficiently
(Figure 9B). These results indicate that benzoate does
indeed act as an inducer Pben509, and not necessarily a
Anthranilate (A) and benzoate (B) promoter regions Figure 2
Anthranilate (A) and benzoate (B) promoter regions. 
The largest promoter region tested for each is shown. 
Pant311 = bases 413–713 (A, dotted underline), Pben278 = 
bases 236–509 (B), Pben87 = bases 236–323 (B, dotted 
underline). Underlined with solid lines are the putative -35 
and -10 sites. A 9 bp direct repeat is show in italics (A). Puta-
tive XylS- type activator binding sites are shown in italics (B). 
The transcriptional start for each promoter is shown in bold. 
Double underlined in B is 5' end of the benA coding region.
A
CTCGCTCATC GCCGCACGGG TGATTACCAC CTGCAACTTG CGGCAGTCAC CGGAAATCGC 60
CAGCACCTGA TGCTCATTGG GCGAAATGAT CACGCCTTGG TCGCGGTTGG AACTGAGACG 120
TTCACCGTTC TTGCTCAGCT CCTGCTCGCC CACCAGTGGC AGGCTCAAGC TGTAGCTGCT 180
GAAGTGCTCG GCGTCTTCGA TGTCGATGGT CACATCAGTG CCGTACTCGA TCACGCCCAG 240
GGTGGTGGCG CGGGATTTGA ACACGTTGGC GCTGTGGTGA AAGCGCAGGC GCTCGGGGGT 300
TGCCGTCGCC AGGCGATGGG GCCCGCAGAT GCCGGACATC CAGCTGCGCG CGCCTTCCAG 360
GTCGAAGCGT TGAATATGAA TATCGCGTGT CTGACTAGTC ATCAGGGTGC ACCCACGGCG 420
GTTAGGCGTT TGCGCGCTCT GACGGCGCGT CGTTGAACCT CGACAGCAAG TTCCAGGCCA 480
CGCCAGTGCA GTTCTCACTG GGTGGATAGC AACGGTCGAC TATGTGGATA AACCCCAGAG 540
TTTTGCGACC ATCGCCCGCC ATCACAGTAG CGCATGCCGT CACCGGCGCG CACCGTCATG 600
GGTATTTGCC GCCCAACTTT GCGGCCTACG TTCCCCCATT AAGCGGATAG CCCGCCACCG 660
CATCGCAGCC GCTTAATGGC TCACCGTTTA GCCATGATCA AAAGGTGCCT CCC 713
B.
CCAACGTCAG TGAACGTTCG CTGTACAGCC TGTTTGAGCG CCAGGTGGGG CTGTCGCCGC 60
GCGATTACGT ACGCCGCTGC AAGCTCGAAC GCGTACATGC ACGCTTGCAA CTAAGCAGCA 120
CGCGCAGCGT GACCGAGGTG GCTTTGGACC ATGGGTTCAT GCACCTAGGG CGGTTTTCCG 180
AAGCCTATCG CAAACGCTTC GGCGAACTGC CGTCGCAGAC CTGGAAACGC CATCGTTAAG 240
CGACGTGCGC CTGGCGGATA GCGATGTGCA GGCAGCGGAT ATTGACGGGC AGGGCGAGCA 300
CGTACGGTGA GGGCGCCTGA TACAAGAACA ACGGAGGGCC CGCCCCATGA TCAGTACACT 360
CGACCGACTC GCCTGCCAAT TGCGCGAGTC CGTACAGGAA GACCCCGCCA CTGGGGTGTT 420
CCGCTGCCGC CGCGACATCT TCACCGACCC CGACCTGTTT GCCCTGGAGA TGAAACACAT 480
CTTCGAAGGC GGGTGGATCT ACCTGGCCC 509Microbial Cell Factories 2006, 5:1 http://www.microbialcellfactories.com/content/5/1/1
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downstream metabolite. This conclusion is consistent
with the observation that Pben509 was not induced by
cis-cis-muconate (data not shown).
Discussion
The work presented here describes the anthranilate and
benzoate catabolic operons of P. fluorescens strain MB101.
The anthranilate dioxygenase large and small subunits
(AntA and AntB) and reductase (AntC) are most closely
related to the anthranilate dioxygenase and reductase
recently described in P. resinovorans. Although the tran-
scriptional activator, AntR, is also closely related to the
transcriptional activator of P. resinovorans, the chromo-
somal arrangement of P. fluorescens antR gene in relation
to the antABC is different than that of P. resinovorans [10].
The P. fluorescens antR gene is divergently transcribed from
the  antABC  operon, similar to the arrangement of the
anthranilate dioxygenase operon of B. cepacia [13]. The P.
fluorescens AntR represents further evidence of an AraC/
XylS type transcriptional activator regulating anthranilate
dioxygenase expression. Transcriptional activators for
anthranilate operons have only recently been described
[10,13]. Studies of antABC promoter activation presented
here indicate that AntR may be the limiting factor in
expression from the Pant promoter. Addition of antR in
multicopy results in significant improvement of Pant
activity (Figure 3) indicating that the presence of presum-
ably higher levels of inducer alone was not sufficient to
promote high levels of gene expression from the Pant pro-
moter. It is possible that either AntR is produced at low
Effect of benR inactivation on Pben278 activity Figure 4
Effect of benR inactivation on Pben278 activity. Above 
is shown β-galactosidase activity (A) of either wild type 
(MB101) or benR inactivated (MB101 benR::kan) carrying 
pDOW1019. Cultures were grown in M9 medium supple-
mented with 1% glucose and induced with 2 mM benzoate 
for 24 hours. Standard deviation of triplicate wells is depicted 
by error bars. A representative experiment is shown. Ben-
zoate metabolism over the course of the induction is shown 
in B, with benzoate concentration shown on the Y-axis and 
time post induction shown on the X-axis.
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levels, or that the protein binds weakly to the promoter
region. In either case, increasing the overall concentration
of the protein would result in improved promoter activity.
The rapid metabolism of anthranilate in the pDOW1035
harbouring strain supports the observation that overex-
pression of antR results in improved Pant activity, since
increased activity of the chromosomally located Pant pro-
moter would result in increased expression of the anthra-
nilate dioxygenase, and subsequently, increased
anthranilate metabolism. Although AntR shows high
homology to other AraC/XylS transcriptional activators,
we were unable to detect a consensus XylS type DNA bind-
ing site (TGCA-N6-GGNTA) [20] upstream of the Pant
core promoter. Further investigation of AntR expression
and elucidation of its binding site in the Pant promoter
may help to improve promoter activity. The Pben pro-
moter fragment, however, does appear to have a XylS type
DNA binding site as shown in italics in Figure 2B. The
sequences TGCG-N6-GGATA and TGCA-N6-GGATA, sep-
arated by 5 bp, are located immediately upstream of the
putative -35 signal. Further investigation is required to
determine whether these sequences are important for
Pben activation. Unlike the antR-Pant system, increasing
the copy number of benR did not improve Pben activity
(data not shown).
Anthranilate and benzoate have been shown to be induc-
ers of the Pant and Pben promoters, respectively, as
expected. Not unexpectedly, several other compounds
were found to induce the promoters. m-toluate, which has
been shown to induce other benzoate operons, including
those of Rhodococcus sp. strain 19070 [16] and P. putida
mt-2 [11], was found to induce the Pben promoter 13-
fold over background. o-toluate, which has not been pre-
viously reported to induce either benzoate or anthranilate
operon promoters, was found to induce the Pant pro-
moter 19-fold. However, o-toluate induction of the Pben
promoter, along with p-toluate induction, was only 2.5 to
3-fold over background. The anthranilate promoter was
also inducible with 6-chloro-anthranilate. The fact that 6-
chloro-anthranilate was not metabolized significantly by
P. fluorescens strain MB101 indicates that 6-chloro-anthra-
nilate acts as a gratuitous inducer, and that anthranilate
itself, and not necessarily a metabolite of anthranilate,
may act as an inducer. Benzoate was shown to be the
inducer of the Pben promoter by deleting the genes cod-
Induction of antR-Pant by 6-chloro-anthranilate Figure 6
Induction of antR-Pant by 6-chloro-anthranilate. 
Above is shown a time course of Pant induction (MB101 car-
rying pDOW1035) performed in M9 media supplemented 
with 1% glucose. Cultures, induced with either 2 mM anthra-
nilate (diamonds) or 2 mM 6-chloro-anthranilate (squares), 
were monitored for β-galactosidase activity (A) and inducer 
concentration (B) as shown on the Y-axes. Time post induc-
tion in hours is shown on the X-axes. Standard deviation of 
triplicate wells is depicted by error bars. A representative 
experiment is shown.
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Induction of antR-Pant and Pben278 by toluate Figure 5
Induction of antR-Pant and Pben278 by toluate. 
Shown on the X-axis is β-galactosidase activity of Pben278 
and antR-Pant constructs (pDOW1028 and pDOW1035 
respectively) 8 hours post-induction. Cultures were grown in 
M9 medium supplemented with 1% glucose. The inducer (5 
mM) used in each case is as described in the legend to the 
right of the bar graph. Standard deviation of triplicate wells is 
depicted by error bars. A representative experiment is 
shown.
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ing for the benzoate dioxygenase large and small subu-
nits. As shown in Figure 9, the Pben promoter remains
active in the absence of benzoate metabolism.
For Pben and Pant to be used as part of an expression sys-
tem, it is important to identify inducing compounds that
are not metabolized by the host organism. We have
shown that the Pben and antR-Pant promoters can drive
heterologous gene expression at the 20 L fermentation
scale. Although the Pben promoter appears to be
repressed under the glucose feed conditions used at the 20
L fermentations scale, the antR-Pant promoter construct
was found to be active. However, a change in carbon
source from glucose to glycerol alleviated the observed
Pben repression at the 20 L scale. Additional fermentation
optimization may result in improved promoter activity
and heterologous gene expression. Further strain develop-
ment, such as chromosomal deletion of the anthranilate
and benzoate dioxygenases should also improve expres-
sion during the course of induction and simplify the
induction process, in that the inducer will not need to be
added more than once during the course of induction to
maintain expression levels.
Conclusion
It is important to identify and develop several recom-
binant expression systems to allow for flexibility and reli-
ability in protein production. The availability of more
than one inducible expression system will allow for differ-
ential expression of proteins during production. Differen-
tial expression of chaperones, foldases or disulfide bond
isomerases from these alternate expression systems may
aid in overall yield of active target protein. We have shown
that the benzoate and anthranilate promoters examined
in this work can be used to drive recombinant protein
expression in P. fluorescens at both small (shake flask) and
Promoter activity at the 20 L scale Figure 8
Promoter activity at the 20 L scale. Induction of 
Pben278:lacZ with ~6 mM benzoate (A) and induction of 
antR-Pant:lacZ with 5 or 10 mM anthranilate (B) are shown 
above. β-galactosidase activity is shown on the Y-axes, and 
time post induction in hours is shown on the X-axes. Stand-
ard deviation of triplicate wells is depicted by error bars. A 
representative experiment is shown.
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Mapping transcriptional start sites of Pben and Pant promot- ers Figure 7
Mapping transcriptional start sites of Pben and Pant 
promoters. Shown above (A) are primer extension prod-
ucts of 30 µg RNA isolate from MB101 carrying pDOW1028 
(Pben278) induced with benzoate run next to the sequence 
ladder generated with the same primer (GATC). Shown in 
(B) is the primer extension product of 10 or 30 µg RNA iso-
lated from MB101 carrying pDOW1029 (Pant713) induced 
with anthranilate is run to the right of a sequence ladder 
(ACGT) generated with the same primer. The DNA 
sequence of the Pben278 promoter is shown in (C). with the 
bold, underlined C indicating the transcriptional start site. 
The putative -35 and -10 regions are shown in italics and 
underlined and the 5' portion of the benA coding sequence is 
shown in bold italics. The 3' portion of the Pant promoter 
fragment is show in (D), with the transcriptional start site 
indicated in bold and underlined and the translational start in 
bold italics. The putative -35 and -10 regions are shown in 
italics and underlined.
AB
C.
GTTAAGCGAC GTGCGCCTGG CGGATAGCGA TGTGCAGGCA GCGGATATTG ACGGGCAGGG
CGAGCACGTA CGGTGAGGGC GCCTGATACA AGAACAACGG AGGGCCCGCC CCATGATCAG
TACACCCGAC CGACTCGCCT GCCAATTGCG CGAGTCCGTA CAGGAAGACC CCGCCACTGG
GGTGTTCCGC TGCCGCCGCG ACATCTTCAC CGACCCCGAC CTGTTTGCCC TGGAGATGAA
ACACATCTTC GAAGGCGGGT GGATCTACCT GGCCC
D.
GGTATTTGCC GCCCAACTTT GCGGCCTACG TTCCCCCATT AAGCGGATAG CCCGCCACCG
CATCGCAGCC GCTTAATGGC TCACCGTTTA GCCATGATCA AAAGGTGCCT CCCATG
GATC 3 0 ACGT1 0 3 0 GATC 3 0 ACGT1 0 3 0Microbial Cell Factories 2006, 5:1 http://www.microbialcellfactories.com/content/5/1/1
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large (20 L) scales. Further development of these pro-
moter systems will aid in expression of complex proteins
in P. fluorescens.
Methods
Bacterial strains and growth conditions
Bacterial strains and plasmids used are listed in Tables 1
and 4. All plasmid construction and propagation was per-
formed using JM109 (Promega, Madison, WI) as a host
cell, functional assays were performed in P. fluorescens
MB101 or derivatives of MB101 as described. The P. fluo-
rescens strain MB214 is a derivative of MB101, which con-
tains the E. coli lacZYA operon integrated into the genome.
Tetracycline was used at a concentration of 15 µg/ml in
both E. coli and P. fluorescens hosts; kanamycin was used
at a concentration of 50 µg/ml in both E. coli and P. fluo-
rescens hosts; ampicillin was used at a concentration of
100  µg/ml in E. coli hosts. Cells were grown on LB
medium (Difco, Becton Dickenson, Sparks, MD), or when
indicated minimal medium consisting of 1XM9 salts
(Difco, Becton Dickenson, Sparks, MD), trace elements
and either glucose, citrate or glycerol as a carbon source as
indicated. E. coli strains were grown at 37°C, while P. flu-
orescens strains were grown at 30°C.
20 L fermentation
P. fluorescens fermentations were conducted in standard,
aerated 20 L research fermentors with a mineral salts
medium derived from Riesenberg, et al. [21]. Cultures
were grown at 32°C and pH 6.5–7.0 was maintained
through the addition of aqueous ammonia. Agitation and
sparged airflow rates were gradually increased during the
growth phase of the fermentation to control dissolved
oxygen at a positive level (15% of saturation) but were
fixed at maximum levels when these were reached. The
cultures were operated as either a glucose or glycerol fed-
batch or as a glycerol batch (glycerol concentration <200
g/L). The fermentation process was divided into an initial
cell growth phase (typically 24–30 hours) and a gene
expression (induction) phase in which inducer was added
(anthranilate or sodium benzoate solution delivered as a
bolus or fed) to initiate recombinant gene expression.
General cloning methods
Restriction digestion, ligation and polymerase chain reac-
tion were performed essentially as described in Sambrook
and Russell. [22]. Restriction enzymes and modifying
enzymes were purchased from New England Biolabs (Bev-
erly, MA), and Taq polymerase was purchased from either
Promega or Invitrogen (Carlsbad, CA). Genomic DNA
was prepared using the Easy DNA isolation kit (Invitro-
gen) according to the manufacturer's protocol. Plasmid
DNA was prepared using the Nucleospin or Nucleobond
plasmid DNA kit (Clontech, Valencia, CA) according to
the manufacturer's protocol. Primers used in this work are
described in Table 5. P. fluorescens plasmids used in this
study are derived from RSF1010 [23].
Construction of benzoate promoter fusions
The Pben509 promoter fragment was amplified using the
ben40PL and ben40PU primers with MB214 genomic
DNA as template. The resulting fragment was digested
with Pac I and BamH I and cloned into pDOW1017 to
produce the Pben509::lacZ  fusion pDOW1019. The
Pben278 promoter fragment was amplified using primers
benL278 and ben40PU, using pDOW1026 as template.
PCR product was purified on a Microcon YM-100 column
(Millipore, Billerica, MA). The PCR product was digested
with Pac I and BamH I and cloned into the same sites of
pNEB193 to produce pDOW1022. The BamH I-Pac I frag-
ment of pDOW1022 containing the Pben278 fragment
was then cloned into pDOW1017 to produce
pDOW1028, a Pben278::lacZ fusion.
Analysis of Pben509 activity in a ∆benAB strain Figure 9
Analysis of Pben509 activity in a ∆benAB strain. Shown 
is β-galactosidase activity of DC253 carrying pDOW1019 
(Pben509::lacZ) uninduced (0 mM benzoate) or induced with 
5 mM sodium benzoate (A). Standard deviation is depicted by 
error bars. Cultures were grown in LB medium supple-
mented with uracil and proline. Benzoate metabolism in the 
parental strain (DC164, ∆pyrF) compared to the ∆benAB 
strain (DC253, ∆pyrF∆benAB) is shown in B.
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Construction of anthranilate promoter fusions
The Pant713 Promoter was amplified using primers
antPU and antPL and MB214 genomic DNA as the tem-
plate. The resulting fragment was cloned into pDOW1017
to produce the Pant713::lacZ  fusion pDOW1029. The
Pant311 promoter was amplified using primers ant311
and antPL+SD using MB214 genomic DNA as the tem-
plate. The PCR product was purified with a Microcon YM-
100 column (Millipore) and the volume brought up to 50
µl with 5 mM Tris-Cl, pH8.0 (~100 ng/µl). The PCR prod-
uct was cloned into the pGEM-T Easy vector (Promega)
and sequenced using M13F and M13R primers. The pGEM
clone was digested with BamH I and Pac I then cloned
into the same sites of pDOW1033 creating a
Pant311::phoA fusion, pDOW1055.
Construction of promoter fusions with transcriptional 
activators
The putative benzoate operon transcriptional activator
gene that lies upstream of benA was amplified using the
primers benact5 and benact3, using MB214 genomic
DNA as template. An ~1.2 kb fragment was isolated using
the Prep-a-Gene kit (Biorad, Hercules, CA), digested with
Pme I and Hind III and cloned into the same sites to
pNEB193 (New England Biolabs) to produce
pDOW1021. The Pme I – Hind III fragment of
pDOW1021 was then cloned into the same sites of
pDOW1019, upstream of the Pben509::lacZ fusion.
The anthranilate operon transcriptional activator that lies
upstream of antA  was amplified using the 3'antactiv
primer and antPL+SD primer using MB214 genomic DNA
as template. An ~1.3 kb fragment was purified using the
Prep-a-Gene kit (Biorad), digested with Hind III and
BamH I and cloned into the same sites to pNEB193 to
produce pDOW1020. The BamH I -Hind III fragment of
pDOW1020 was then cloned into the same site of
pDOW1017 to produce pDOW1035.
β-galactosidase assay
Strains of interest were grown overnight (30°C shaking at
250 rpm) in 1× M9 supplemented with 1% (w/v) glucose,
1 mM MgSO4 and trace elements. Strains were then sub-
cultured and induced with indicated concentrations of
anthranilate or benzoate. β-galactosidase activity of sam-
ples was analyzed in a 96-well format. For each sample
well, buffer was prepared as follows: 152 µl Z buffer (0.06
M Na2HPO4-7H2O, 0.04 M NaH2PO4-H2O, 0.01 M KCl,
0.001 M MgSO4-7H20) was mixed with 8 µl 1 M β-mer-
captoethanol. Buffer was prepared in bulk quantities: to
each 900 µl of this mix were added 1 drop 0.1%SDS and
2 drops CHCl3, and vortexed to mix. In each well, 144 µl
of the above reaction mix and 16 ul of cells were com-
bined. The microtiter plate was sealed and vortexed for 10
seconds, then equilibrated at room temperature for 5
minutes before addition of 50 µl 4 mg/ml 2-nitrophenyl
β-D-galactopyranoside (ONPG). When a significant yel-
low color developed, 90 µl stop solution (1 M Na2CO3)
was added and time was recorded. Reactions were read at
A420 and A550, soon after stopping the reaction; cell den-
sity was read at A600. Miller Units were calculated as fol-
lows: 1000 * ((A420 - (1.75*A550))/(time (in minutes) *
0.1 * A600)). An average of triplicate wells is reported for
each sample.
Table 4: Plasmids Used in This Study
Plasmid Relevant Feature Source
PCR2.1 TOPO Cloning vector Invitrogen
pNEB193 Cloning vector New England Biolabs
pGEM-T Easy Cloning vector Promega
pDOW1017 Promoterless lacZ This work
pDOW1019 Pben509::lacZ This work
pDOW1020 antR-Pant This work
pDOW1021 benR This work
pDOW1022 Pben278 This work
pDOW1026 Pben509 This work
pDOW1028 Pben278::lacZ This work
pDOW1029 Pant713::lacZ This work
pDOW1033 Promoterless phoA This work
pDOW1035 antR Pant::lacZ This work
pDOW1041 Pben278::phoA This work
pDOW1055 Pant311::phoA This work
pDOW1081 Pben88::phoA This work
pDOW1101 Pant311::lacZ This work
pDOW1131 400 bp benR fragment This work
pDOW1139 3' benR + 5' benC This work
pDOW1261-2 tetAR pyrF This workMicrobial Cell Factories 2006, 5:1 http://www.microbialcellfactories.com/content/5/1/1
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Analysis of anthranilate and benzoate concentrations
HPLC analyses of culture supernatant was carried out on
a Hewlett-Packard Series 1100 HPLC using an isocratic
method capable of separating anthranilate, benzoate, cat-
echol, 6-chloroanthranilate and o-toluate. The separation
column was a ZORBAX Eclipse XDB-C8 (4.6 × 150 mm, 5
µm; Agilent P/N 993967-906) equipped with a Supel-
guard Discovery C18 guard column (4 × 20 mm; Supelco
P/N 505129). The mobile phase contained 25% ace-
tonitrile in 25 mM sodium dihydrogen phosphate
(NaH2PO4), pH 2.5, and the flow rate was 1.0 mL/min.
The method used a standard sample injection volume of
2.5  µL and compounds were detected by monitoring
absorbance at 254 nm. Under these conditions, com-
pound retention times were as follows: catechol (2.20
min), 6-chloroanthranilate (3.01 min), anthranilate (3.46
min), benzoate (4.98 min), and o-toluate (6.53 min).
Area responses were linear (R2 0.99) for calibration stand-
ards ranging from 0.5 to 5.0 mM.
RNA Isolation
An overnight culture of MB101 carrying the appropriate
plasmid was grown in 1× M9 supplemented with 1% glu-
cose (w/v), 1 mM MgSO4 and trace elements. The culture
was induced with 5 mM benzoate or anthranilate as
appropriate for 8 or 24 hours. Cells were pelleted and
total RNA isolated using RNeasy maxi kit (Qiagen). The
RNA was resuspended to a final volume of 200 µl and
treated with 10 units DNAseI (RNase free) (Ambion)
according to manufacturer's protocol. Following DNAseI
treatment, the RNA was purified using an RNeasy midi or
mini column (Qiagen). RNA concentration was deter-
mined using Ribogreen (Molecular Probes).
Primer extension
Primer Labeling:1 µl 10 µM primer (either lacZPE or
lacZPE2), 1 µl 10× T4 kinase buffer, 5 µl 32P γ ATP (50 uCi,
Amersham Biosciences, Pistcataway, NJ), 1 µl T4 kinase, 2
µl ddH2O, was incubated at 37°C for 30–60 minutes. 5 µl
of the reaction was reserved to use for sequencing ladder.
20 µl TE was added to the remaining 5 µl and purified
using a G25 sephadex column (Amersham-Pharmacia) to
remove unincorporated nucleotides, yielding a final con-
centration of 0.2 µM labelled primer.
Sequencing ladder: The Promega fmol kit, along with 1
µM labelled primer was used to generate a sequencing lad-
der. Plasmid template used corresponds with that con-
tained in the strain from which RNA was isolated for the
extension reaction.
Table 5: Primers Used in This Study
Primer Name Sequence
phoA5bam CGGGATCCGGGCCTCCTTGCGGGT
phoA3Xho CCGCTCGAGTTATTTCAGCCCCAGAGC
ant311 CCTTAATTAACAGGGTGCACCCACG
antPL+SD CGGGATCCGGGAGGCACCTTTTGATCAT
antPL CGGGATCCCTTTTGATCATGGCTAAC
antPU GCTCTAGACTCGCTCATCGCCGCACG
AntAKO5 GGAATTCTTCGTGACGATGCG
AntAKO3 CGGGATCCGCTCGCGATGCTGC
lacZPE GGATGTGCTGCAAGGC
lacZPE2 GTAACCATGGTCATCGC
ben40PU CGGGATCCGGGCCAGGTAGATCCAC
ben40PL CCTTAATTAACCAACGTCAGTGAACGTTC
benactko-for CGCGACACATTGCTGCCCAG
benactko-rev AGTATCAGCCATCGCACCTT
benL278 CCTTAATTAAGTTAAGCGACGTGCGC
3' antactiv CCCAAGCTTCTATCGAGGCAAGCCAG
benact5' AGCTTTGTTTAAACGCATGACGTTGTTGATTC
benact3' CCCAAGCTTCCCGTCAATATCCGCTG
H3_5'benAKOclean CCCAAGCTTGCCATGAGGCGGAAAACGCTGC
H3_3'benBKOclean CCCAAGCTTCGGTGATCGCCACGCTGTCGC
benKOmega CATACGTCATGGCCCTCCGTTGTTC
invbenKOmega GAACAACGGAGGGCCATGACGTATG
5'benA_seq CTGCTGGAAAACGCCTGCCTGGAG
seq_3'benB GAGCACTTCAAGCATCGACAGGAAC
1261-8378F CTTCAGATCCAGACTCACCAG
1261-103R GACCATGATTACGCCAAGCGC
M13F GTAAAACGACGGCCAGT
M13R CACACAGGAAACAGCTATGACMicrobial Cell Factories 2006, 5:1 http://www.microbialcellfactories.com/content/5/1/1
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Primer Extension reaction: 10–20 µg of total RNA was
mixed with 0.2 pmol primer to yield a final volume of 12
µl, and incubated at 70C for 10 min. To this was added 4
µl 5× Superscript II buffer, 2 µl 1 M DTT, 1 µl 10 mM
dNTPs, 1 µl Superscript II or Thermoscript Reverse tran-
scriptase (Invitrogen) and incubated 42°C (Superscript)
or 55°C (Thermoscript) for 1 hour. 4 µl of sequencing
stop solution was added to the reaction. All reactions were
heated at 70°C for 2 minutes immediately before being
loaded onto a 6% Long Ranger (Biowhittaker, Rockland,
ME)/8 M urea/1.2× TBE gel next to the sequencing ladder.
The gel was run in 0.6× TBE buffer, then dried, exposed to
phophor screen, and imaged on the Typhoon pho-
phorimager (Molecular Dynamics).
Inactivation of benzoate transcriptional activator
A DNA fragment containing a portion of the open reading
frame (ORF) upstream of the benA gene was amplified by
PCR using MB214 genomic DNA as template with the
benactKO-for and benactKO-rev primers. JM109 was
transformed with the resulting product cloned into the
pCR2.1 TOPO vector (Invitrogen). Transformants were
screened for insert by colony PCR using M13F and M13R
primers, and the positive clones were further confirmed
by DNA sequencing. The resulting plasmid, pDOW1131,
was used to insertionally inactivate the corresponding
ORF. P. fluorescens strain MB101 was transformed with
pDOW1131, selecting on LB agar supplemented with tet-
racycline. Primers benactKO-for and either M13F or
M13R were used to confirm insertion of the plasmid into
the desired ORF by colony PCR. The resulting strain was
named DC284.
Construction of P. fluorescens ∆benAB∆proC∆pyrF
Following the method previously described for construc-
tion of gene deletions in P. fluorescens [24], the plasmid
pDOW1139 was constructed to facilitate deletion of the
benAB genes as follows. The 3' portion of the benR gene
and the 5' portion of the benC gene were amplified using
MB214 genomic DNA as template. The benR region was
amplified using primers H3_5'benAKOclean and
benKOmega. The benC region was amplified using prim-
ers H3_3'benBKOclean and invbenKOmega. The benR
and benC fragments were fused using primers H3_5'benA-
KOclean and H3_3'benBKOclean with both fragments as
template. The expected 1.1 kb fragment was gel-purified
using Qiaex II (Qiagen) and cloned into Srf I digested
pDOW1261-2[24].  P. fluorescens MB101 derivative
DC164 [24] was transformed with the resulting plasmid,
pDOW1139. Transformants were selected by plating on
LB-proline-uracil with tetracycline for selection. Since the
plasmid could not replicate in P. fluorescens, tetracycline
resistant colonies isolated following transformation
resulted from the plasmid integration into the chromo-
some. The site of plasmid integration was analyzed by
PCR. To obtain strains that have lost the integrated plas-
mid by recombination between the homologous regions,
single colonies of the transformants were inoculated into
liquid LB supplemented with 250 µg/mL each proline and
uracil (LB-proline-uracil), grown overnight, and then
plated onto LB-proline-uracil and 500 µg/mL 5'-
fluoroorotic acid (FOA) to counter select for the loss of
the plasmid [25]. Isolates having the phenotype expected
(i.e., tetracycline sensitive, uracil auxotrophic, and FOA
resistant) were selected. DNA from the resulting strain
(DC253) was analyzed by PCR to confirm removal of the
benAB  region using primers 5'benA_seq, seq_3'benB,
M13R21, 1261-8378F and 1261-103R.
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